{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:12:13Z","timestamp":1789423933440,"version":"build-2803163510"},"reference-count":55,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Venous thromboembolism (VTE) complicates \u223c 1 to 2 of 1000 pregnancies, with pulmonary embolism being a leading cause of maternal mortality and deep vein thrombosis an important cause of maternal morbidity, also on the long term. However, a strong evidence base for the management of pregnancy-related VTE is missing. Management is not standardized between physicians, centers, and countries. The management of pregnancy-related VTE is based on extrapolation from the nonpregnant population, and clinical trial data for the optimal treatment are not available. Low-molecular-weight heparin (LMWH) in therapeutic doses is the treatment of choice during pregnancy, and anticoagulation (LMWH or vitamin K antagonists postpartum) should be continued until 6 weeks after delivery with a minimum total duration of 3 months. Use of LMWH or vitamin K antagonists does not preclude breastfeeding. Whether dosing should be based on weight or anti-Xa levels is unknown, and practices differ between centers. Management of delivery, including the type of anesthesia if deemed necessary, requires a multidisciplinary approach, and several options are possible, depending on local preferences and patient-specific conditions.<\/jats:p>","DOI":"10.1182\/blood-2011-04-306589","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T07:20:19Z","timestamp":1316157619000},"page":"5394-5400","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["How I treat pregnancy-related venous thromboembolism"],"prefix":"10.1182","volume":"118","author":[{"given":"Saskia","family":"Middeldorp","sequence":"first","affiliation":[{"name":"Academic Medical Center, Department of Vascular Medicine, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"5","key":"2019111807440770500_B1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2019111807440770500_B2","first-page":"1","article-title":"Pregnancy-related mortality surveillance: United States, 1991-1999.","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"issue":"5","key":"2019111807440770500_B3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/ejvs.2001.1499","article-title":"A 16-year haemodynamic follow-up of women with pregnancy-related medically treated iliofemoral deep venous thrombosis.","volume":"22","author":"Rosfors","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"10","key":"2019111807440770500_B4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"6","key":"2019111807440770500_B5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1538-7836.2008.02961.x","article-title":"Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study.","volume":"6","author":"Jacobsen","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111807440770500_B6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study.","volume":"5","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111807440770500_B7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study.","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111807440770500_B8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation.","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"2019111807440770500_B9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-151-2-200907210-00004","article-title":"Predicting deep venous thrombosis in pregnancy: out in \u201cLEFt\u201d field?","volume":"151","author":"Chan","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"2019111807440770500_B10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1538-7836.2010.03783.x","article-title":"D-dimer testing in pregnant patients: towards determining the next \u201clevel\u201d in the diagnosis of DVT.","volume":"8","author":"Chan","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111807440770500_B11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1538-7836.2005.01779.x","article-title":"Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review.","volume":"4","author":"Nijkeuter","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111807440770500_B12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0038-1646557","article-title":"Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease.","volume":"61","author":"Ginsberg","year":"1989","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111807440770500_B13","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1538-7836.2004.00929.x","article-title":"Diagnosing pulmonary embolism in pregnancy: rationalizing fetal radiation exposure in radiological procedures.","volume":"2","author":"Nijkeuter","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2019111807440770500_B14","first-page":"CD003074","article-title":"Once versus twice daily LMWH for the initial treatment of venous thromboembolism.","author":"van Dongen","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2019111807440770500_B15","doi-asserted-by":"crossref","first-page":"454S","DOI":"10.1378\/chest.08-0658","article-title":"Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Kearon","year":"2008","journal-title":"Chest"},{"issue":"6","key":"2019111807440770500_B16","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1378\/chest.130.6.1808","article-title":"Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?","volume":"130","author":"Ferretti","year":"2006","journal-title":"Chest"},{"issue":"2","key":"2019111807440770500_B17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular- weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807440770500_B18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06826.x","article-title":"The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.","volume":"139","author":"Voke","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111807440770500_B19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.2007.01622.x","article-title":"Antenatal pulmonary embolism: risk factors, management and outcomes.","volume":"115","author":"Knight","year":"2008","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"2019111807440770500_B20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0049-3848(99)00228-5","article-title":"Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients: a prospective cohort study.","volume":"98","author":"Crowther","year":"2000","journal-title":"Thromb Res"},{"issue":"9","key":"2019111807440770500_B21","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1471-0528.2002.01525.x","article-title":"Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series.","volume":"109","author":"Rodie","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"2019111807440770500_B22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1471-0528.2003.02182.x","article-title":"Low molecular weight heparin (dalteparin) for the treatment of venous thromboembolism in pregnancy.","volume":"110","author":"Jacobsen","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"2019111807440770500_B23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajog.2004.05.050","article-title":"A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain the rapeutic levels of anticoagulation.","volume":"191","author":"Barbour","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2019111807440770500_B24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0020-7292(00)00290-3","article-title":"Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin.","volume":"71","author":"Rey","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2019111807440770500_B25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9378(03)00953-0","article-title":"Tinzaparin sodium for thrombosis treatment and prevention during pregnancy.","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"2019111807440770500_B26","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"2","key":"2019111807440770500_B27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111807440770500_B28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/tera.10054","article-title":"Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis.","volume":"66","author":"van Driel","year":"2002","journal-title":"Teratology"},{"issue":"2","key":"2019111807440770500_B29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"2019111807440770500_B30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1160\/TH06-02-0108","article-title":"Vitamin K antagonists and pregnancy outcome: a multi-centre prospective study.","volume":"95","author":"Schaefer","year":"2006","journal-title":"Thromb Haemost"},{"issue":"2","key":"2019111807440770500_B31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-3782(01)00140-2","article-title":"Neurological outcome in school-age children after in utero exposure to coumarins.","volume":"63","author":"Wesseling","year":"2001","journal-title":"Early Hum Dev"},{"issue":"4","key":"2019111807440770500_B32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-0037-1615641","article-title":"Coumarins during pregnancy: long-term effects on growth and development of school-age children.","volume":"85","author":"Wesseling","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111807440770500_B33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1160\/TH04-06-0345","article-title":"Treatment of 51 pregnancies with danaparoid because of heparin intolerance.","volume":"93","author":"Lindhoff-Last","year":"2005","journal-title":"Thromb Haemost"},{"issue":"18","key":"2019111807440770500_B34","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","article-title":"Minor transplacental passage of fondaparinux in vivo.","volume":"350","author":"Dempfle","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807440770500_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2009.03.001","article-title":"Treatment options in massive pulmonary embolism during pregnancy: a case-report and review of literature.","volume":"124","author":"te Raa","year":"2009","journal-title":"Thromb Res"},{"issue":"1","key":"2019111807440770500_B36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2010.06.003","article-title":"Thrombolysis for massive pulmonary embolism in pregnancy: a report of three cases and follow up over a two year period.","volume":"127","author":"Holden","year":"2011","journal-title":"Thromb Res"},{"issue":"11","key":"2019111807440770500_B37","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies.","volume":"108","author":"Lepercq","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"2019111807440770500_B38","first-page":"1237","article-title":"Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.","volume":"98","author":"Bauersachs","year":"2007","journal-title":"Thromb Haemost"},{"issue":"1","key":"2019111807440770500_B39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14767050400028626","article-title":"The safety of low molecular weight heparin therapy during labor.","volume":"17","author":"Maslovitz","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"2019111807440770500_B40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.jp.7211745","article-title":"Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.","volume":"27","author":"Kominiarek","year":"2007","journal-title":"J Perinatol"},{"key":"2019111807440770500_B41","doi-asserted-by":"crossref","first-page":"e000257","DOI":"10.1136\/bmjopen-2011-000257","article-title":"Risk of early postpartum hemorrhage in women receiving therapeutic doses of low-molecular-weight heparin.","volume":"1","author":"Roshani","year":"2011","journal-title":"BMJ Open"},{"issue":"2","key":"2019111807440770500_B42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijoa.2009.06.008","article-title":"Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs.","volume":"19","author":"Butwick","year":"2010","journal-title":"Int J Obstet Anesth"},{"issue":"4","key":"2019111807440770500_B43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1538-7836.2003.t01-7-00115.x","article-title":"High rate of skin complications due to low-molecular-weight heparins in pregnant women.","volume":"1","author":"Bank","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111807440770500_B44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00002018-199920060-00005","article-title":"Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.","volume":"20","author":"Wutschert","year":"1999","journal-title":"Drug Saf"},{"issue":"7","key":"2019111807440770500_B45","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1538-7836.2010.03795.x","article-title":"Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia.","volume":"8","author":"Schindewolf","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111807440770500_B46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00404-004-0615-0","article-title":"Skin reactions due to low-molecular-weight heparin in pregnancy: a strategic dilemma.","volume":"271","author":"Verdonkschot","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"2019111807440770500_B47","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"issue":"4","key":"2019111807440770500_B48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","article-title":"Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin.","volume":"168","author":"Dahlman","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2019111807440770500_B49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.","volume":"87","author":"Pettila","year":"2002","journal-title":"Thromb Haemost"},{"issue":"5","key":"2019111807440770500_B50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/deh115","article-title":"Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control.","volume":"19","author":"Carlin","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"2019111807440770500_B51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0037-1614988","article-title":"Pharmacodynamics and tolerance of two nadroparin formulations (10,250 and 20,500 anti Xa IU\/mL) delivered for 10 days at therapeutic dose.","volume":"79","author":"Boneu","year":"1998","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111807440770500_B52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1479-828X.2009.01004.x","article-title":"Use of a retrievable inferior vena cava filter in term pregnancy: case report and review of literature.","volume":"49","author":"Milford","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"2019111807440770500_B53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00270-008-9393-6","article-title":"Failed retrieval of an inferior vena cava filter during pregnancy because of filter tilt: report of two cases.","volume":"32","author":"McConville","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"2019111807440770500_B54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00609589","article-title":"May mothers taking acenocoumarol breast feed their infants?","volume":"21","author":"Houwert-de Jong","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"2019111807440770500_B55","first-page":"938","article-title":"Coumarin derivatives and breast-feeding.","volume":"95","author":"Clark","year":"2000","journal-title":"Obstet Gynecol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/20\/5394\/1346814\/zh804611005394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/20\/5394\/1346814\/zh804611005394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T19:10:11Z","timestamp":1712862611000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/20\/5394\/29752\/How-I-treat-pregnancyrelated-venous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":55,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2011,11,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-04-306589","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}